Genocea Biosciences (GNCA) Misses Q4 EPS by 11c
Tweet
Share
E-mailGet Alerts GNCA Hot Sheet
Join SI Premium – FREE
Genocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.66), $0.11 worse than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
